1. MicroRNA‑432 inhibits the aggressiveness of glioblastoma multiforme by directly targeting IGF‑1R
   Xudong Chen et al, 2019, International Journal of Molecular Medicine CrossRef
2. Elucidating the mechanisms of Temozolomide resistance in gliomas and the strategies to overcome the resistance.
   Manendra Singh Tomar et al, 2021, Biochimica et Biophysica Acta (BBA) - Reviews on Cancer CrossRef
3. MicroRNAs in adult high-grade gliomas: Mechanisms of chemotherapeutic resistance and their clinical relevance
   Yugendran Jegathesan et al, 2024, Biomedicine & Pharmacotherapy CrossRef
4. Downregulation of TUSC3 promotes EMT and hepatocellular carcinoma progression through LIPC/AKT axis
   Ruxia Deng et al, 2022, Journal of Translational Medicine CrossRef
5. MicroRNA-based therapy for glioblastoma: Opportunities and challenges
   Qingchun Lei et al, 2023, European Journal of Pharmacology CrossRef
6. The Roles of miRNA in Glioblastoma Tumor Cell Communication: Diplomatic and Aggressive Negotiations
   Andrei Buruiană et al, 2020, International Journal of Molecular Sciences CrossRef
7. Association between microRNAs 10b/21/34a and acute toxicity in glioblastoma patients treated with radiotherapy and temozolomide
   Aleksandar Stepanović et al, 2022, Scientific Reports CrossRef
8. Signaling pathways governing glioma cancer stem cells behavior
   Ava Nasrolahi et al, 2023, Cellular Signalling CrossRef
9. Epigenetic Activation of TUSC3 Sensitizes Glioblastoma to Temozolomide Independent of MGMT Promoter Methylation Status
   Qiong Wu et al, 2023, International Journal of Molecular Sciences CrossRef
10. The Role of microRNAs in Multidrug Resistance of Glioblastoma
    Parvaneh Mahinfar et al, 2022, Cancers CrossRef
11. MiR-132 inhibits migration and invasion and increases chemosensitivity of cisplatin-resistant oral squamous cell carcinoma cells via targeting TGF-β1
    Liqiang Chen et al, 2020, Bioengineered CrossRef
12. Non-coding RNAs and glioma: Focus on cancer stem cells
    Ali Rajabi et al, 2022, Molecular Therapy - Oncolytics CrossRef
13. Aberrant miRNAs Regulate the Biological Hallmarks of Glioblastoma
    Wanli Yu et al, 2018, NeuroMolecular Medicine CrossRef
14. Temozolomide Resistance: A Multifarious Review on Mechanisms Beyond O-6-Methylguanine-DNA Methyltransferase
    Vanishree Rao et al, 2023, CNS & Neurological Disorders - Drug Targets CrossRef
15. DNA Damage Repair Genes and Noncoding RNA in High-Grade Gliomas and Its Clinical Relevance
    Tanvi R. Parashar et al, 2022, Central Nervous System Tumors CrossRef
16. Molecular mechanisms of the microRNA-132 during tumor progressions
    Meysam Moghbeli et al, 2021, Cancer Cell International CrossRef
17. miRNA signature in glioblastoma: Potential biomarkers and therapeutic targets
    Omidvar Rezaei et al, 2020, Experimental and Molecular Pathology CrossRef
18. Molecular Mechanisms of Drug Resistance in Glioblastoma
    Maya A. Dymova et al, 2021, International Journal of Molecular Sciences CrossRef
19. Targeting Epigenetic Regulators in Cancer to Overcome Resistance to Targeted Therapy
    Mukesh Verma et al, 2019, Current Applications for Overcoming Resistance to Targeted Therapies CrossRef
20. Non-coding RNAs in drug resistance of head and neck cancers: A review
    Fengsheng Dai et al, 2020, Biomedicine & Pharmacotherapy CrossRef
21. Recent advances of the regulation roles of MicroRNA in glioblastoma
    Chengrui Yan et al, 2020, International Journal of Clinical Oncology CrossRef